Camrelizumab Plus Carboplatin, Nab-Paclitaxel Shows Efficacy in ES-SCLC
Housing Assistance May Help Renters With Cancer Better Withstand Medical Financial Strain
Many Patients With Advanced Cancer Report Care Misaligned With Their Goals
Innovation vs Affordability: Cancer Care’s Cost Crisis and Access Gap
Overcoming Barriers to Molecular Testing in NSCLC Care: Jorge Nieva, MD
Improving Clinical Trial Diversity Through Language-Inclusive Approaches: Daniel Virnich, MD
Clinical Considerations for Immunotherapy Sequencing in NSCLC: Lauren Antrim, MD
Balancing Safety, Cost, and Duration in Immunotherapy for NSCLC: Lauren Antrim, MD
Addressing Financial and Socioeconomic Barriers to Precision NSCLC Care: Jonathan Thompson, MD, MS
Insurance Delays Add Costs to CAR T-Cell Therapy: Ravi Vij, MD, MBA
Weighing Relapse Risk Against Benefit in Advanced NSCLC Immunotherapy: Jonathan Thompson, MD, MS
CAR T and Bispecifics Pose Different Challenges in Blood Cancer Treatment: Ravi Vij, MD, MBA
Navigating Perioperative Immunotherapy Decisions in Lung Cancer Care: Jonathan Thompson, MD, MS
Refining Treatment Timelines and Immunotherapy Strategies in Early-Stage NSCLC: Jonathan Thompson, MD, MS
Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
Oncology Onward: A Conversation With OneOncology’s Dr Jeff Patton
Health Equity Conversations: Improving Diversity of Oncology Care Staff
Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity
Reforming Oncology Care Payments: Interviews From the QCCA Leadership Summit
What Are the Next Steps for Collaboration, Accountability in Oncology Care First?
KOL Corner: Amy Ellis Discusses Value-Based Cancer Rehab With Amanda Hodges
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care